Cargando…

MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea

BACKGROUND: Methylating agents such as N-methyl-N-nitrosourea (MNU) can cause cell cycle arrest and death either via caspase-dependent apoptosis or via a poly(ADP-ribose) polymerase (PARP)-dependent form of apoptosis. We wished to investigate the possible role of MLH1 in signalling cell death throug...

Descripción completa

Detalles Bibliográficos
Autores principales: McDaid, J R, Loughery, J, Dunne, P, Boyer, J C, Downes, C S, Farber, R A, Walsh, C P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720233/
https://www.ncbi.nlm.nih.gov/pubmed/19623177
http://dx.doi.org/10.1038/sj.bjc.6605186
_version_ 1782170122655367168
author McDaid, J R
Loughery, J
Dunne, P
Boyer, J C
Downes, C S
Farber, R A
Walsh, C P
author_facet McDaid, J R
Loughery, J
Dunne, P
Boyer, J C
Downes, C S
Farber, R A
Walsh, C P
author_sort McDaid, J R
collection PubMed
description BACKGROUND: Methylating agents such as N-methyl-N-nitrosourea (MNU) can cause cell cycle arrest and death either via caspase-dependent apoptosis or via a poly(ADP-ribose) polymerase (PARP)-dependent form of apoptosis. We wished to investigate the possible role of MLH1 in signalling cell death through PARP. METHODS: Fibroblasts are particularly dependent on a PARP-mediated cell death response to methylating agents. We used hTERT-immortalised normal human fibroblasts (WT) to generate isogenic MLH1-depleted cells, confirmed by quantitative PCR and western blotting. Drug resistance was measured by clonogenic and cell viability assays and effects on the cell cycle by cell sorting. Damage signalling was additionally investigated using immunostaining. RESULTS: MLH1-depleted cells were more resistant to MNU, as expected. Despite having an intact G(2)/M checkpoint, the WT cells did not initially undergo cell cycle arrest but instead triggered cell death directly by PARP overactivation and nuclear translocation of apoptosis-inducing factor (AIF). The MLH1-depleted cells showed defects in this pathway, with decreased staining for phosphorylated H2AX, altered PARP activity and reduced AIF translocation. Inhibitors of PARP, but not of caspases, blocked AIF translocation and greatly decreased short-term cell death in both WT and MLH1-depleted cells. This MLH1-dependent response to MNU was not blocked by inhibitors of ATM/ATR or p53. CONCLUSION: These novel data indicate an important role for MLH1 in signalling PARP-dependent cell death in response to the methylating agent MNU.
format Text
id pubmed-2720233
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27202332010-08-04 MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea McDaid, J R Loughery, J Dunne, P Boyer, J C Downes, C S Farber, R A Walsh, C P Br J Cancer Translational Therapeutics BACKGROUND: Methylating agents such as N-methyl-N-nitrosourea (MNU) can cause cell cycle arrest and death either via caspase-dependent apoptosis or via a poly(ADP-ribose) polymerase (PARP)-dependent form of apoptosis. We wished to investigate the possible role of MLH1 in signalling cell death through PARP. METHODS: Fibroblasts are particularly dependent on a PARP-mediated cell death response to methylating agents. We used hTERT-immortalised normal human fibroblasts (WT) to generate isogenic MLH1-depleted cells, confirmed by quantitative PCR and western blotting. Drug resistance was measured by clonogenic and cell viability assays and effects on the cell cycle by cell sorting. Damage signalling was additionally investigated using immunostaining. RESULTS: MLH1-depleted cells were more resistant to MNU, as expected. Despite having an intact G(2)/M checkpoint, the WT cells did not initially undergo cell cycle arrest but instead triggered cell death directly by PARP overactivation and nuclear translocation of apoptosis-inducing factor (AIF). The MLH1-depleted cells showed defects in this pathway, with decreased staining for phosphorylated H2AX, altered PARP activity and reduced AIF translocation. Inhibitors of PARP, but not of caspases, blocked AIF translocation and greatly decreased short-term cell death in both WT and MLH1-depleted cells. This MLH1-dependent response to MNU was not blocked by inhibitors of ATM/ATR or p53. CONCLUSION: These novel data indicate an important role for MLH1 in signalling PARP-dependent cell death in response to the methylating agent MNU. Nature Publishing Group 2009-08-04 2009-07-21 /pmc/articles/PMC2720233/ /pubmed/19623177 http://dx.doi.org/10.1038/sj.bjc.6605186 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Translational Therapeutics
McDaid, J R
Loughery, J
Dunne, P
Boyer, J C
Downes, C S
Farber, R A
Walsh, C P
MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
title MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
title_full MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
title_fullStr MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
title_full_unstemmed MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
title_short MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
title_sort mlh1 mediates parp-dependent cell death in response to the methylating agent n-methyl-n-nitrosourea
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720233/
https://www.ncbi.nlm.nih.gov/pubmed/19623177
http://dx.doi.org/10.1038/sj.bjc.6605186
work_keys_str_mv AT mcdaidjr mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea
AT lougheryj mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea
AT dunnep mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea
AT boyerjc mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea
AT downescs mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea
AT farberra mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea
AT walshcp mlh1mediatesparpdependentcelldeathinresponsetothemethylatingagentnmethylnnitrosourea